Popular Articles From: Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe to NeuroDerm CEO to Present at Oppenheimer Healthcare Conference on December 10, 2014


SALT LAKE CITY and ZURICH, Oct.
Sign-up for Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe investment picks
SALT LAKE CITY, Dec.
Sign-up for Myriad to Present Eight Studies at 2014 San Antonio Breast Cancer Symposium investment picks
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that multiple posters for the Prosigna ® Breast Cancer Gene Signature Assay based on PAM50 will be presented at the 37 th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). These include a prospective study of the Prosigna Assay on adjuvant clinical decision-making in women with Estrogen Receptor-Positive (ER+), HER2-negative, node-negative breast cancer.
Sign-up for NanoString Technologies Announces Prosigna Presentations at the 2014 CTRC-AACR San Antonio Breast Cancer Symposium investment picks
New Multi-Year Term License Contract Includes International Scope ATLANTA , Nov.
Sign-up for NantHealth Signs Contract To Add Streamline Health's Looking Glass® Clinical Analytics Solution To Its Cloud-Based Intelligent Clinical Operating Systems investment picks
Jeff Gordon and Ray Evernham's 1999 No.24 Pepsi Chevrolet to Benefit Jeff Gordon Children's Foundation LAS VEGAS , Nov.
Sign-up for NASCAR Legends Jeff Gordon And Ray Evernham Restore Iconic Stock Car For Charity; Car To Be Featured At Barrett-Jackson Scottsdale On Velocity investment picks
2014/10/13
NEW YORK and SAN FRANCISCO, Oct.
Sign-up for Nasdaq Educational Foundation to Open Entrepreneurial Center in San Francisco investment picks
Strongest year for listings at Nasdaq since 2000 with 189 IPOs NEW YORK, Dec.
Sign-up for Nasdaq Secures #1 Position for Total IPOs at U.S. Exchanges in 2014 investment picks
ORLANDO, Fla.
Sign-up for National Retail Properties, Inc. Prices Offering Of Common Stock investment picks
Tucson Community Sustains Its "Appetite" for Natural Food Choices TUCSON, Ariz.
Sign-up for Natural Grocers Set to Open Store in Tucson on January 20 investment picks
Reports organic revenue growth of 5% for the third quarter Reports record Q3 non-GAAP EPS of $0.33 Increases annual revenue and non-GAAP earnings guidance PLEASANTON, Calif., Oct.
Sign-up for Natus Medical Announces Record Third Quarter and Year-to-Date 2014 Financial Results investment picks
NEWARK, Del., Nov.
Sign-up for Navient to acquire $8.5 billion in federal student loans from Wells Fargo investment picks
Next year, the healthcare system will be front and center as the Supreme Court rules on the constitutionality of health insurance exchange subsidies and changes to the Affordable Care Act (ACA) continue.
Sign-up for Navigant Center for Healthcare Research and Policy Analysis Identifies Key Areas to Watch in 2015 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153691&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for Navigator Holdings Ltd. Announces Date for the Release of Third Quarter 2014 Results, Conference Call and Webcast investment picks
2014/12/16
http://media.marketwire.com/attachments/201101/19589_navios.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165289&ProfileId=051205&sourceType=1 MONACO --
Sign-up for Navios Maritime Holdings Inc. Declares Quarterly Dividend of $54.6875 per Share on Its Series G Preferred Stock; Quarterly Dividend of $53.90625 per Share on Its Series H Preferred Stock investment picks
2014/12/15
National concern about the high cost of higher education typically focuses on higher tuition costs.
Sign-up for Neebo Survey Finds College Students Worry More About Textbook Costs Than College Tuition for Spring Semester investment picks
-- Findings Presented at 2014 San Antonio Breast Cancer Symposium (SABCS) -- SAN ANTONIO and SAN FRANCISCO , Dec.
Sign-up for Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3 BEACON Study of Etirinotecan Pegol (NKTR-102) in Patients with Advanced Breast Cancer investment picks
- GAAP net income $1.84 per share, $1.45 per share excluding adjustments - Servicing $130.8 billion student loans for 5.8 million borrowers under government contract - 32 percent increase in payment processing revenue driven by RenWeb acquisition LINCOLN, Neb.
Sign-up for Nelnet Reports Third Quarter 2014 Results investment picks
STOCKHOLM, Sweden, Dec.
Sign-up for Neonode to Demonstrate Cutting Edge Touch Technologies at CES 2015 investment picks
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, announced the presentation of the novel design of its Phase 3 Pyridorin PIONEER clinical program at the American Society of Nephrology (ASN) Kidney Week meeting held here November 11-16, 2014.
Sign-up for NephroGenex, Inc. Announces Presentation at the American Society of Nephrology’s Kidney Week 2014 investment picks
2015/1/8
By John Revill ZURICH--Nestlé SA said Thursday it was selling a piece of its Spanish frozen food operation, part of the Swiss food giant's move to hive off fringe businesses.
Sign-up for Nestlé to Sell Part of Its Spanish Frozen Food Operation investment picks
World's Leading Internet Television Network to Offer Original Series, Movies, Documentaries, Stand-Up Comedy Specials and TV Shows for Low Monthly Price LOS GATOS, Calif.
Sign-up for Netflix To Launch In Australia And New Zealand In March 2015 investment picks
2014/11/17
NEW YORK , Nov.
Sign-up for Neuberger Berman Closed-End Intermediate Municipal Funds Announce Monthly Distributions investment picks
2014/12/31
NEW YORK , Dec.
Sign-up for Neuberger Berman MLP Income Fund Announces Monthly Distributions investment picks
REHOVOT, Israel, Dec.
Sign-up for NeuroDerm CEO to Present at Oppenheimer Healthcare Conference on December 10, 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe to NeuroDerm CEO to Present at Oppenheimer Healthcare Conference on December 10, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent